Plasma cells: a feasible therapeutic target in pulmonary fibrosis?

Eur Respir J. 2022 Nov 24;60(5):2201748. doi: 10.1183/13993003.01748-2022. Print 2022 Nov.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Bleomycin
  • Fibroblasts / pathology
  • Humans
  • Plasma Cells
  • Pulmonary Fibrosis* / drug therapy
  • Pulmonary Fibrosis* / pathology

Substances

  • Bleomycin